Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Immunome Inc (NASDAQ: IMNM) closed at $9.35 in the last session, down -1.79% from day before closing price of $9.52. In other words, the price has decreased by -$1.79 from its previous closing price. On the day, 0.81 million shares were traded.
Ratios:
We take a closer look at IMNM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.JP Morgan initiated its Overweight rating on April 30, 2024, with a $24 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when SIEGALL CLAY B bought 150,000 shares for $7.75 per share. The transaction valued at 1,162,500 led to the insider holds 669,636 shares of the business.
SIEGALL CLAY B bought 66,057 shares of IMNM for $630,263 on Nov 21 ’24. The President and CEO now owns 485,693 shares after completing the transaction at $9.54 per share. On Nov 22 ’24, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 33,943 shares for $9.78 each. As a result, the insider paid 331,918 and bolstered with 519,636 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 78.16 while its Price-to-Book (P/B) ratio in mrq is 2.63.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $8.97. The 50-Day Moving Average of the stock is -13.03%, while the 200-Day Moving Average is calculated to be -27.34%.
Shares Statistics:
A total of 84.67M shares are outstanding, with a floating share count of 69.67M. Insiders hold about 17.73% of the company’s shares, while institutions hold 63.10% stake in the company.
